QuantumSi Inc (QSI) - Net Assets
Based on the latest financial reports, QuantumSi Inc (QSI) has net assets worth $220.23 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($245.61 Million) and total liabilities ($25.38 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of QuantumSi Inc to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $220.23 Million |
| % of Total Assets | 89.67% |
| Annual Growth Rate | 35.55% |
| 5-Year Change | -53.83% |
| 10-Year Change | N/A |
| Growth Volatility | 460.4 |
QuantumSi Inc - Net Assets Trend (2019–2025)
This chart illustrates how QuantumSi Inc's net assets have evolved over time, based on quarterly financial data. Also explore QuantumSi Inc balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for QuantumSi Inc (2019–2025)
The table below shows the annual net assets of QuantumSi Inc from 2019 to 2025. For live valuation and market cap data, see market cap of QuantumSi Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $220.23 Million | +2.23% |
| 2024-12-31 | $215.42 Million | -20.69% |
| 2023-12-31 | $271.62 Million | -24.28% |
| 2022-12-31 | $358.71 Million | -24.80% |
| 2021-12-31 | $477.03 Million | +1221.83% |
| 2020-12-31 | $36.09 Million | +1.70% |
| 2019-12-31 | $35.48 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to QuantumSi Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 56235000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $22.00K | 0.01% |
| Other Comprehensive Income | $-6.00K | 0.00% |
| Other Components | $918.19 Million | 416.93% |
| Total Equity | $220.23 Million | 100.00% |
QuantumSi Inc Competitors by Market Cap
The table below lists competitors of QuantumSi Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hamilton Beach Brands Holding Co Class A
NYSE:HBB
|
$188.20 Million |
|
ODFJELL TECHNOLOGYLTD
F:ND4
|
$188.24 Million |
|
Seven Hills Realty Trust
NASDAQ:SEVN
|
$188.25 Million |
|
Gulf Island Fabrication Inc
NASDAQ:GIFI
|
$188.30 Million |
|
Mobase Electronics Co.Ltd
KQ:012860
|
$188.15 Million |
|
Central Industrial Corp
KLSE:8052
|
$188.15 Million |
|
Staude Capital Global Value Fund Ltd
AU:GVF
|
$188.07 Million |
|
TEN SQUARE GAMES SA
WAR:TEN
|
$187.99 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in QuantumSi Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 215,420,000 to 220,226,000, a change of 4,806,000 (2.2%).
- Net loss of 101,339,000 reduced equity.
- New share issuances of 93,510,000 increased equity.
- Other comprehensive income decreased equity by 51,000.
- Other factors increased equity by 12,686,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-101.34 Million | -46.02% |
| Share Issuances | $93.51 Million | +42.46% |
| Other Comprehensive Income | $-51.00K | -0.02% |
| Other Changes | $12.69 Million | +5.76% |
| Total Change | $- | 2.23% |
Book Value vs Market Value Analysis
This analysis compares QuantumSi Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.86x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.69x to 0.86x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $0.26 | $0.96 | x |
| 2020-12-31 | $6.71 | $0.96 | x |
| 2021-12-31 | $5.99 | $0.96 | x |
| 2022-12-31 | $2.58 | $0.96 | x |
| 2023-12-31 | $1.92 | $0.96 | x |
| 2024-12-31 | $1.50 | $0.96 | x |
| 2025-12-31 | $1.11 | $0.96 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently QuantumSi Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -46.02%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4160.06%
- • Asset Turnover: 0.01x
- • Equity Multiplier: 1.12x
- Recent ROE (-46.02%) is above the historical average (-55.35%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -100.96% | 0.00% | 0.00x | 1.06x | $-39.34 Million |
| 2020 | -101.45% | 0.00% | 0.00x | 1.12x | $-40.22 Million |
| 2021 | -19.91% | 0.00% | 0.00x | 1.05x | $-142.69 Million |
| 2022 | -36.92% | -28854.47% | 0.00x | 1.09x | $-168.31 Million |
| 2023 | -35.33% | -8868.76% | 0.00x | 1.10x | $-123.12 Million |
| 2024 | -46.89% | -3303.04% | 0.01x | 1.15x | $-122.55 Million |
| 2025 | -46.02% | -4160.06% | 0.01x | 1.12x | $-123.36 Million |
Industry Comparison
This section compares QuantumSi Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,432,799,891
- Average return on equity (ROE) among peers: -74.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| QuantumSi Inc (QSI) | $220.23 Million | -100.96% | 0.12x | $188.18 Million |
| Abbott Laboratories (ABT) | $24.16 Billion | 9.46% | 0.81x | $155.56 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-13.54K | 0.00% | 0.00x | $21.60 Million |
| Aethlon Medical Inc (AEMD) | $9.29 Million | -84.45% | 0.15x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $2.15 Million | -112.84% | 0.45x | $16.04 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $8.60 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.22 Million |
| Artivion Inc (AORT) | $89.39 Million | 8.74% | 0.25x | $1.73 Billion |
| Apyx Medical Inc (APYX) | $21.15 Million | 2.82% | 0.30x | $125.55 Million |
About QuantumSi Inc
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for … Read more